These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14826106)

  • 21. Certain 5-phenyl-5-(substituted phenyl)-hydantoins.
    MELTON JW; HENZE HR
    J Am Chem Soc; 1947 Aug; 69(8):2018-20. PubMed ID: 20255296
    [No Abstract]   [Full Text] [Related]  

  • 22. [Exfoliative dermatitis after hydantoin therapy].
    HATZMANN I; NEUHOLD R; VON RITTNER W
    Ann Paediatr; 1952 Nov; 179(5):305-16. PubMed ID: 13017343
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical evaluation of 1-methyl-5,5-phenyl-ethyl-hydantoin in the treatment of epilepsy.
    LIVINGSTON S; PAULI LL; KRAMER I; NAJMABADI A
    N Engl J Med; 1961 Aug; 265():418-21. PubMed ID: 13762831
    [No Abstract]   [Full Text] [Related]  

  • 24. [Molecular structure and anticonvulsive effect. The effect of substitutions in the nuclei of barbituric acid and hydantoin].
    MERCIER J
    C R Seances Soc Biol Fil; 1950 Dec; 144(23-24):1677-78. PubMed ID: 14822376
    [No Abstract]   [Full Text] [Related]  

  • 25. [Neurologic manifestations associated with chronic hydantoin poisoning].
    POMME B; GIRARD J; GIBERT J
    Ann Med Psychol (Paris); 1962 Dec; 120(2)():707-10. PubMed ID: 13972096
    [No Abstract]   [Full Text] [Related]  

  • 26. [Our experiences in the treatment of epilepsy with methyl-phenyl-ethyl-hydantoin].
    ROGER J; ROGER A
    Prog Med (Paris); 1958 Feb; 86(4):67. PubMed ID: 13527523
    [No Abstract]   [Full Text] [Related]  

  • 27. Pulmonary changes in hydantoin therapy.
    MOORE MT
    J Am Med Assoc; 1959 Nov; 171():1328-33. PubMed ID: 14423879
    [No Abstract]   [Full Text] [Related]  

  • 28. Epilepsy; treatment with new drug; 3-methyl 5,5-phenyl-ethyl-hydantoin (phenantoin).
    KOZOL HL
    Am J Psychiatry; 1946 Sep; 103(2):154-8. PubMed ID: 21001983
    [No Abstract]   [Full Text] [Related]  

  • 29. [Two fatal cases of aplastic anemia caused by mesantoin (methylphenylethyl hydantoin)].
    BENHAMOU E; ALBOU A
    Alger Medicale; 1952; 56(7):389-92. PubMed ID: 12996423
    [No Abstract]   [Full Text] [Related]  

  • 30. The absorption spectra of organic compounds containing nitrogen; derivatives of hydantoin.
    STUCKEY RE
    J Chem Soc; 1947 Mar; 169():331-4. PubMed ID: 20240567
    [No Abstract]   [Full Text] [Related]  

  • 31. Spirodon (tetrantoin): a new anticonvulsant of the hydantoin group.
    PUTNAM TJ; JACOBS J
    Neurology; 1957 Nov; 7(11):784-8. PubMed ID: 13483836
    [No Abstract]   [Full Text] [Related]  

  • 32. Another fatality following the use of tridione and an hydantoin.
    GAYLE RF; LYNCH JP; SCHERER JH
    Va Med Mon (1918); 1948 Jun; 75(6):288-91. PubMed ID: 18868603
    [No Abstract]   [Full Text] [Related]  

  • 33. The non-availability of lysine from the corresponding hydantoin in the rat.
    PAGE E; GAUDRY R; GINGRAS R
    Can J Res; 1947 Dec; 25(6):207-9. PubMed ID: 18919691
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of N-methylation in 5,5-disubstituted derivatives of barbituric acid, hydantoin, and 2-4-oxazolidinedione.
    BUTLER TC
    J Am Pharm Assoc Am Pharm Assoc; 1955 Jun; 44(6):367-70. PubMed ID: 14381308
    [No Abstract]   [Full Text] [Related]  

  • 35. [Two cases of hydantoin poisoning in children].
    NOVOTNY J
    Prakt Lek; 1953 Aug; 33(15):347-9. PubMed ID: 13100211
    [No Abstract]   [Full Text] [Related]  

  • 36. [Erythroderma due to diphenyl hydantoin].
    VERMENOUZE ; HERMABESSIERE O
    Bull Soc Fr Dermatol Syphiligr; 1951; 58(5):543. PubMed ID: 14925749
    [No Abstract]   [Full Text] [Related]  

  • 37. The reaction of pyrrolealdehyde with rhodanine and hydantoin.
    HERZ W; DITTMER K
    J Am Chem Soc; 1948 Feb; 70(2):503. PubMed ID: 18907739
    [No Abstract]   [Full Text] [Related]  

  • 38. Displacement of thyroxine from human thyroxine-binding globulin by analogues of hydantoin. Steric aspects of the thyroxinebinding site.
    OPPENHEIMER JH; TAVERNETTI RR
    J Clin Invest; 1962 Dec; 41(12):2213-20. PubMed ID: 13940236
    [No Abstract]   [Full Text] [Related]  

  • 39. A METHOD FOR EVALUATION OF PHYSIOLOGICAL AVAILABILITY OF DIPHENYL HYDANTOIN BY URINARY ANALYSIS.
    PANALAKS T
    Clin Chim Acta; 1963 Nov; 8():968-70. PubMed ID: 14089572
    [No Abstract]   [Full Text] [Related]  

  • 40. The hydrolysis of hydantoin by various tissues.
    BERNHEIM F; BERNHEIM ML
    J Biol Chem; 1946 Jun; 163():683-5. PubMed ID: 20985639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.